CCL2 and breast carcinoma: CCL2 expression is also elevated by radiotherapy in breast cancer [107], colon cancer [258], head and neck squamous cell carcinoma [138], and pancreatic ductal adenocarcinoma [259], which leads to the resistance of these cells to radiotherapy [138,258,259,260] and causes their migration and then metastasis [261].